Companies researching Keytruda (pembrolizumab)

Keytruda (pembrolizumab) is a humanized monoclonal antibody used in cancer immunotherapy to treat melanoma, lung, head‑and‑neck, Hodgkin lymphoma, stomach, cervical and certain breast cancers, administered via intravenous infusion.

List of companies that research Keytruda (pembrolizumab)

CompanyCountryIndustryEmployeesRevenueTechnologies
Country flag

United States

Biotechnology Research

325

Keytruda (pembrolizumab)

Country flag

United States

Biotechnology Research

249

Keytruda (pembrolizumab)

Country flag

Canada

Financial Services

1.3k

Keytruda (pembrolizumab)

Country flag

United States

Pharmaceutical Manufacturing

3.4k

$15M

Keytruda (pembrolizumab)

Country flag

Italy

Hospitals and Health Care

5.9k

Keytruda (pembrolizumab)

Country flag

United States

Business Consulting and Services

97

$18M

Keytruda (pembrolizumab)

Country flag

United States

Hospitals and Health Care

21k

$5.5B

Keytruda (pembrolizumab)

Country flag

Denmark

Government Administration

10k

Keytruda (pembrolizumab)

Country flag

Netherlands

Hospitals and Health Care

10k

$3.8M

Keytruda (pembrolizumab)

Country flag

United States

Hospitals and Health Care

1k

$4.2M

Keytruda (pembrolizumab)

Showing top companies out of 35 that research Keytruda (pembrolizumab). Get the full list on TheirStack.

Frequently asked questions